中国血液净化

中国血液净化 ›› 2022, Vol. 21 ›› Issue (06): 445-448,460.doi: doi:10.3969/j.issn.1671-4091.2022.06.014

• 综述 • 上一篇    下一篇

腹膜透析相关性腹膜纤维化机制的研究进展

马龙飞     杜 路   邓喜文   胡爽爽   郭明好   

  1. 新乡医学院第一附属医院肾内科
  • 收稿日期:2022-01-20 修回日期:2022-04-02 出版日期:2022-06-12 发布日期:2022-06-12
  • 通讯作者: 郭明好 13937315636@163.com E-mail:13937315636@163.com

Research progress on the mechanism of peritoneal fi-brosis associated with peritoneal dialysis

  • Received:2022-01-20 Revised:2022-04-02 Online:2022-06-12 Published:2022-06-12
  • Contact: GUO Ming-hao 13937315636@163.com E-mail:13937315636@163.com

PDF

350

摘要： 腹膜透析(peritoneal dialysis，PD)是终末期肾病(end state renal disease，ESRD)重要的肾脏替代治疗方式之一，在提升患者生活质量的同时，也伴随着诸多并发症，其中腹膜纤维化(peritoneal fibrosis，PF)被认为是导致PD失败的最主要原因。为了促进PD技术的发展与应用，使其造福更多临床患者，众多学者对PF的发生机制展开了研究，现将近年来的发现作一综述。

关键词: 终末期肾病, 腹膜透析, 腹膜纤维化

Abstract: Peritoneal dialysis (PD) is one of the important renal replacement treatments for end stage renal disease (ESRD). PD improves the patients’ quality of life but also has many complications, in which peritoneal fibrosis (PF) is considered to be the main cause of PD failure. In order to promote the development and application of PD technology and to benefit more ESRD patients, many scholars have conducted researches on the mechanism of PF. This paper reviews the recent achievements in this area.

Key words: End stage renal disease, Peritoneal dialysis, Peritoneal fibrosis

中图分类号: